Sustained-release formulations of capsaicin are being explored for extended anticancer activity. Recently in Pharmacology & Therapeutics, the article chronicles the growth-suppressive activity of sustained-release capsaicin drugs, including solid dispersion systems, liposomes, phospholipid complexes, and nanoparticles.
‘Developing different delivery systems like encapsulating capsaicin in long-acting sustained release drug delivery systems could allow for consistent capsaicin levels to be efficient as anticancer agents.’
Read More..Tweet it Now
This is the first publication to provide an in-depth description of the anticancer activity of capsaicin sustained-release formulations. The research team was led by Piyali Dasgupta and Monica Valentovic.Read More..
“This review article is the first to provide a comprehensive overview of capsaicin formulations in human cancer. Previous publications in the literature only briefly address sustained-release formulations of capsaicin,” said Dasgupta.
The nutritional agent capsaicin displayed robust growth-inhibitory activity in a diverse array of human cancers. However, the clinical applications of capsaicin as a viable anticancer agent were hindered by three factors — poor solubility, low bioavailability, and spicy flavor.
“Oral use of capsaicin is associated with unfavorable side effects such as stomach cramps, nausea, a burning sensation in the gut, and gastrointestinal irritation,” said Valentovic.
“A strategy to overcome these drawbacks is the development of different delivery systems, such as encapsulating capsaicin in long-acting sustained release drug delivery systems could allow for more consistent capsaicin levels that could be more efficient as anticancer agents.”
Advertisement
Source-Medindia